Hochschulschrift
The role of amyloid beta 4-42 in the etiology of Alzheimer's disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Göttingen, Georg-August Universität, Diss., 2014
- Schlagwort
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Göttingen
- (wer)
-
Niedersächsische Staats- und Universitätsbibliothek Göttingen
- (wann)
-
2015
- Urheber
-
Bouter, Yvonne
- Beteiligte Personen und Organisationen
-
Bayer, Thomas A.
Hanisch, Uwe-Karsten
Ehrenreich, Hannelore
- Handle
-
11858/00-1735-0000-0023-9978-E
- URN
-
urn:nbn:de:gbv:7-11858/00-1735-0000-0023-9978-E-9
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Bouter, Yvonne
- Bayer, Thomas A.
- Hanisch, Uwe-Karsten
- Ehrenreich, Hannelore
- Niedersächsische Staats- und Universitätsbibliothek Göttingen
Entstanden
- 2015
Ähnliche Objekte (12)
The contribution of N-terminally modified amyloid beta to the etiology of Alzheimer's disease
Amyloid beta 4-42 in Alzheimer’s disease: Target, Therapy, Mechanism
Copper binding to the Alzheimer’s disease amyloid precursor protein
The role of ATP-binding cassette subfamily A in the etiology of Alzheimer’s disease
Exploring the role of common regulatory variants in the etiology of late-onset Alzheimer’s disease
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-β plaques
The amyloid hypothesis of Alzheimer's disease at 25 years
The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease
Degree of amyloid-β burden could be indicative of the primary etiology underlying dementia
Amyloid PET imaging: applications beyond Alzheimer’s disease
The contribution of N-terminally modified amyloid beta to the etiology of Alzheimer's disease
Amyloid beta 4-42 in Alzheimer’s disease: Target, Therapy, Mechanism
Copper binding to the Alzheimer’s disease amyloid precursor protein
The role of ATP-binding cassette subfamily A in the etiology of Alzheimer’s disease
Exploring the role of common regulatory variants in the etiology of late-onset Alzheimer’s disease
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-β plaques
The amyloid hypothesis of Alzheimer's disease at 25 years
The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease
Degree of amyloid-β burden could be indicative of the primary etiology underlying dementia
Amyloid PET imaging: applications beyond Alzheimer’s disease
The contribution of N-terminally modified amyloid beta to the etiology of Alzheimer's disease
Amyloid beta 4-42 in Alzheimer’s disease: Target, Therapy, Mechanism
Copper binding to the Alzheimer’s disease amyloid precursor protein
The role of ATP-binding cassette subfamily A in the etiology of Alzheimer’s disease
Exploring the role of common regulatory variants in the etiology of late-onset Alzheimer’s disease
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-β plaques
The amyloid hypothesis of Alzheimer's disease at 25 years
The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease
Degree of amyloid-β burden could be indicative of the primary etiology underlying dementia